Lyxor Japan (Topix) (Dr) Ucits illékonyság
Mi az Lyxor Japan (Topix) (Dr) Ucits illékonyság?
A illékonyság az Lyxor Japan (Topix) (Dr) Ucits - 29.77%
Mi a illékonyság meghatározása?
A volatilitás vagy az átlagos valódi tartomány százalék (ATRP 14) a záróár százalékában kifejezve.
Average true range percent (ATRP) measures volatility on a relative level. This is opposed to the ATR, which measures volatility on an absolute level. ATRP allows securities to be compared whereas ATR does not. That means lower-priced stocks won't necessarily have lower ATR values than higher-priced stocks.
The period used in the calculation is 14 days and the normalized indicator oscillates between 0 and 100 percent of recent price variation. Importantly, the indicator doesn't predict the direction of price but it describes the current volatility. The volatility is comparable across all securities and all markets.
Volatility expresses the degree of price movement. The use of ATRP as volatility compared to ATR is preferred in cases when different securities or different time periods are compared. Examples are stock screening, filtering strategies, and studying seasonality and volatility patterns over long periods of time and different markets
illékonyság a Miscellaneous szektor a LSE-on cégekben a Lyxor Japan (Topix) (Dr) Ucits -hoz képest
Mit csinál Lyxor Japan (Topix) (Dr) Ucits?
Lyxor UCITS ETF Japan (TOPIX) is an exchange traded fund launched and managed by Lyxor International Asset Management S.A. It invests in the public equity markets of Japan. The fund uses derivatives such as swap agreements to invest in the stocks of companies operating across diversified sectors. It invests in the stocks of large-cap companies. The fund seeks to replicate the performance of the TOPIX Gross Total Return Index, by employing synthetic replication methodology. It was formerly known as Lyxor ETF Japan (TOPIX). Lyxor UCITS ETF Japan (TOPIX) was formed on October 28, 2005 and is domiciled in France.
illékonyság -hoz hasonló cégek Lyxor Japan (Topix) (Dr) Ucits
- Goldstone Resources nak illékonyság 29.68% van
- ObsEva SA nak illékonyság 29.69% van
- Wirecard AG nak illékonyság 29.70% van
- Yunhong International nak illékonyság 29.72% van
- Youngevity International Inc nak illékonyság 29.75% van
- Budding Times nak illékonyság 29.76% van
- Lyxor Japan (Topix) (Dr) Ucits nak illékonyság 29.77% van
- Exprivia S.p.A nak illékonyság 29.79% van
- Monopar Therapeutics Inc nak illékonyság 29.82% van
- NorZinc nak illékonyság 29.88% van
- Pacific Special Acquisition Cor nak illékonyság 29.98% van
- Pacific Special Acquisition Cor nak illékonyság 29.99% van
- Cineworld Plc nak illékonyság 30.00% van